20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective treatment available. An increasing number of genetic causes of ALS are being identified, but how these genetic defects lead to motor neuron degeneration and to which extent they affect common cellular pathways remains incompletely understood. To address these questions, we performed an interactomic analysis to identify binding partners of wild-type (WT) and ALS-associated mutant versions of ATXN2, C9orf72, FUS, OPTN, TDP-43 and UBQLN2 in neuronal cells. This analysis identified several known but also many novel binding partners of these proteins. Interactomes of WT and mutant ALS proteins were very similar except for OPTN and UBQLN2, in which mutations caused loss or gain of protein interactions. Several of the identified interactomes showed a high degree of overlap: shared binding partners of ATXN2, FUS and TDP-43 had roles in RNA metabolism; OPTN- and UBQLN2-interacting proteins were related to protein degradation and protein transport, and C9orf72 interactors function in mitochondria. To confirm that this overlap is important for ALS pathogenesis, we studied fragile X mental retardation protein (FMRP), one of the common interactors of ATXN2, FUS and TDP-43, in more detail in in vitro and in vivo model systems for FUS ALS. FMRP localized to mutant FUS-containing aggregates in spinal motor neurons and bound endogenous FUS in a direct and RNA-sensitive manner. Furthermore, defects in synaptic FMRP mRNA target expression, neuromuscular junction integrity, and motor behavior caused by mutant FUS in zebrafish embryos, could be rescued by exogenous FMRP expression. Together, these results show that interactomics analysis can provide crucial insight into ALS disease mechanisms and they link FMRP to motor neuron dysfunction caused by FUS mutations.

          Electronic supplementary material

          The online version of this article (doi:10.1007/s00401-016-1575-8) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.

          Non-amyloid, ubiquitinated cytoplasmic inclusions containing TDP-43 and its C-terminal fragments are pathological hallmarks of amyotrophic lateral sclerosis (ALS), a fatal motor neuron disorder, and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U). Importantly, TDP-43 mutations are linked to sporadic and non-SOD1 familial ALS. However, TDP-43 is not the only protein in disease-associated inclusions, and whether TDP-43 misfolds or is merely sequestered by other aggregated components is unclear. Here, we report that, in the absence of other components, TDP-43 spontaneously forms aggregates bearing remarkable ultrastructural similarities to TDP-43 deposits in degenerating neurons of ALS and FTLD-U patients [corrected] . The C-terminal domain of TDP-43 is critical for spontaneous aggregation. Several ALS-linked TDP-43 mutations within this domain (Q331K, M337V, Q343R, N345K, R361S, and N390D) increase the number of TDP-43 aggregates and promote toxicity in vivo. Importantly, mutations that promote toxicity in vivo accelerate aggregation of pure TDP-43 in vitro. Thus, TDP-43 is intrinsically aggregation-prone, and its propensity for toxic misfolding trajectories is accentuated by specific ALS-linked mutations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics.

            MaxQuant is a quantitative proteomics software package designed for analyzing large mass spectrometric data sets. It is specifically aimed at high-resolution mass spectrometry (MS) data. Currently, Thermo LTQ-Orbitrap and LTQ-FT-ICR instruments are supported and Mascot is used as a search engine. This protocol explains step by step how to use MaxQuant on stable isotope labeling by amino acids in cell culture (SILAC) data obtained with double or triple labeling. Complex experimental designs, such as time series and drug-response data, are supported. A standard desktop computer is sufficient to fulfill the computational requirements. The workflow has been stress tested with more than 1,000 liquid chromatography/mass spectrometry runs in a single project. In a typical SILAC proteome experiment, hundreds of thousands of peptides and thousands of proteins are automatically and reliably quantified. Additional information for identified proteins, such as Gene Ontology, domain composition and pathway membership, is provided in the output tables ready for further bioinformatics analysis. The software is freely available at the MaxQuant home page.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity.

              Dendritic spines are the major sites of excitatory synaptic input, and their morphological changes have been linked to learning and memory processes. Here, we report that growing microtubule plus ends decorated by the microtubule tip-tracking protein EB3 enter spines and can modulate spine morphology. We describe p140Cap/SNIP, a regulator of Src tyrosine kinase, as an EB3 interacting partner that is predominantly localized to spines and enriched in the postsynaptic density. Inhibition of microtubule dynamics, or knockdown of either EB3 or p140Cap, modulates spine shape via regulation of the actin cytoskeleton. Fluorescence recovery after photobleaching revealed that EB3-binding is required for p140Cap accumulation within spines. In addition, we found that p140Cap interacts with Src substrate and F-actin-binding protein cortactin. We propose that EB3-labeled growing microtubule ends regulate the localization of p140Cap, control cortactin function, and modulate actin dynamics within dendritic spines, thus linking dynamic microtubules to spine changes and synaptic plasticity.
                Bookmark

                Author and article information

                Contributors
                +31 88 7568831 , r.j.pasterkamp@umcutrecht.nl
                Journal
                Acta Neuropathol
                Acta Neuropathol
                Acta Neuropathologica
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0001-6322
                1432-0533
                10 May 2016
                10 May 2016
                2016
                : 132
                : 175-196
                Affiliations
                [ ]Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
                [ ]Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
                [ ]Department of Biology and Biotechnology Charles Darwin and IBPM, Sapienza University of Rome, Rome, Italy
                [ ]Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy
                [ ]Department of (Neuro)Pathology, Academic Medical Center, Amsterdam, The Netherlands
                [ ]Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, The Netherlands
                [ ]Proteomics Center, Erasmus University Medical Center, Rotterdam, The Netherlands
                [ ]Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, The Netherlands
                [ ]Centre for Integrative Physiology, The University of Edinburgh, Edinburgh, UK
                [ ]Department of Molecular Biology and Biochemistry, Graduate School of Medicine, Osaka University, Osaka, Japan
                Article
                1575
                10.1007/s00401-016-1575-8
                4947123
                27164932
                80b1c706-2392-48c9-8fcc-c97221fdabe7
                © The Author(s) 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 22 January 2016
                : 14 April 2016
                : 15 April 2016
                Funding
                Funded by: Fondation Thierry Latran (FR)
                Funded by: FundRef http://dx.doi.org/10.13039/100009281, Fondation Thierry Latran;
                Funded by: FundRef http://dx.doi.org/10.13039/501100004243, Prinses Beatrix Spierfonds;
                Funded by: Netherlands ALS foundation
                Award ID: TOTALS
                Award ID: TOTALS
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100003246, Nederlandse Organisatie voor Wetenschappelijk Onderzoek;
                Award ID: VICI
                Award ID: National Roadmap Large-Scale Research Facilities
                Award Recipient :
                Funded by: European Union
                Award ID: ERC
                Award Recipient :
                Funded by: AriSLA
                Categories
                Original Paper
                Custom metadata
                © Springer-Verlag Berlin Heidelberg 2016

                Neurology
                amyotrophic lateral sclerosis,fmrp ,fus,c9orf72,motor neuron,tdp-43
                Neurology
                amyotrophic lateral sclerosis, fmrp , fus, c9orf72, motor neuron, tdp-43

                Comments

                Comment on this article